Clinical Trial Update: Cladribine in Patients With Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cladribine in mantle cell lymphoma has completed. Sponsored by the Alliance for Clinical Trials in Oncology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Cladribine (cladribine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lymphoma | Phase 2 | Status: COMPLETED